Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
sovaprevir (formerly ACH-1625)
print preview
bookmark
share with colleague
General Information
Company
Achillion Pharmaceuticals Inc.
Description
Selective inhibitor of HCV NS3 protease
Molecular Target
HCV NS3 protease
Mechanism of Action
Viral protease inhibitor
Latest Stage of Development
Phase II
Indication
Hepatitis C virus (HCV)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information